Dupilumab treatment led to significant SCORAD score reductions, with 37% achieving a 75% reduction and 72% reaching mild disease status by week 16. Improvements were observed as early as week 2, with ...

TOKYO, Oct. 11, 2023 /PRNewswire/ -- Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that post-hoc analysis data from the Phase 2b study of rocatinlimab (AMG 451/KHK4083), an investigational product ...

This study developed an AI model that accurately detects body parts and eczema lesions and objectively assesses eczema severity (TIS score), demonstrating strong correlation with ...

Japanese researchers have developed an artificial intelligence (AI) tool that objectively assesses the severity of atopic dermatitis (AD) using user-uploaded photographs. The study, published in the ...